Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase + Enoxaparin vs UFH in Prehospital AMI (ASSENT 3 Plus)
NCT02181998Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2000
- Primary completion
- Aug 2002
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of enoxaparin in myocardial infarction (MI), sponsored by Boehringer Ingelheim. Started Jul 2000; status: completed.
02
Drugs
enoxaparin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT02181998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02181998.